Funding Priority

Activate: Apply the Innovation Mindset and Skillset Across the Journey of an Idea

We support faculty, students and staff who want to put their ideas into practice and thrive in society and the modern innovation economy. Support focuses on three new opportunities: (1) Pathways to Impact Program, (2) Dreamers Who Do Program and (3) Carolina Innovation Passport.

Innovate Carolina

    Hunting down brain tumors

    First, Shawn Hingtgen, Ph.D., and his team figured out how to turn a person’s own skin cells into stem cells that hunt down and mop up the remnants of invasive brain tumors. The breakthrough promises a new and more effective treatment for glioblastoma, the most common form of primary brain cancer and also one of the deadliest.

    Now, Dr. Hingtgen, an assistant professor in the UNC Eshelman School of Pharmacy, has founded a start-up company called Falcon Therapeutics to ensure that this innovative and life-saving treatment reaches patients.

    With the standard treatment for glioblastoma, median survival is less than a year and a half, and the chance of surviving beyond two years is 30 percent. In mouse models, the cancer-hunting stem cells increased time of survival 160 percent to 220 percent, depending on the type of tumor.

    “We’ve gone almost 30 years without a significant improvement in care,” said Dr. Hingtgen, whose work was supported by the Eshelman Institute for Innovation. “Glioblastoma patients desperately need something better.”

    They may very well get it, thanks to him and his fellow Carolina innovators.

     

    Explore Stories

    Portrait of Trenette Goings
    Faculty Support

    Goings the Extra Mile

    Trenette Goings works to prevent addiction

    CITAP Researchers
    Innovation

    Democracy in the Digital Age

    Carolina researchers are helping us understand our digital political spheres

    Vaughn and Nancy Bryson pose facing the camera with Dr. Muenzer
    Health

    New Pediatric Center Named to Honor UNC Doctor

    A new research and treatment program focused on MPS was named in honor of Dr. Joseph Muenzer, Bryson Distinguished Professor in Pediatrics.

    Innovation

    Analyzing Artificial Intelligence

    New lab will understand how to integrate AI into operations management

    Health

    Healing Heart Muscle

    Reprogramming heart muscle cells for healthier outcomes

    Nate Hathaway in the CRISPR Screening Facility
    Research

    UNC-Chapel Hill Awarded Funding for Study of Malan Syndrome

    UNC Eshelman School of Pharmacy and CRISPR Screening Facility collaborate on Malan Syndrome study.